Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.

Suffee N, Le Visage C, Hlawaty H, Aid-Launais R, Vanneaux V, Larghero J, Haddad O, Oudar O, Charnaux N, Sutton A.

Sci Rep. 2017 Oct 16;7(1):13294. doi: 10.1038/s41598-017-13444-7.

2.

Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.

Marinval N, Saboural P, Haddad O, Maire M, Bassand K, Geinguenaud F, Djaker N, Ben Akrout K, Lamy de la Chapelle M, Robert R, Oudar O, Guyot E, Laguillier-Morizot C, Sutton A, Chauvierre C, Chaubet F, Charnaux N, Hlawaty H.

Mar Drugs. 2016 Oct 17;14(10). pii: E185.

3.

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H.

Mar Drugs. 2015 Oct 28;13(11):6588-608. doi: 10.3390/md13116588.

4.

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, Oudar O, Sutton A, Charnaux N.

Biol Open. 2014 Sep 26;3(10):995-1004. doi: 10.1242/bio.20148227.

5.

Synthesis and biological evaluation of new bisphosphonate-dextran conjugates targeting breast primary tumor.

Migianu-Griffoni E, Chebbi I, Kachbi S, Monteil M, Sainte-Catherine O, Chaubet F, Oudar O, Lecouvey M.

Bioconjug Chem. 2014 Feb 19;25(2):224-30. doi: 10.1021/bc400317h. Epub 2014 Jan 22.

PMID:
24400882
6.

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A.

Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.

PMID:
22752444
7.

Angiogenic properties of the chemokine RANTES/CCL5.

Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A.

Biochem Soc Trans. 2011 Dec;39(6):1649-53. doi: 10.1042/BST20110651. Review.

PMID:
22103502
8.

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N.

Biochem Pharmacol. 2011 Jan 15;81(2):233-43. doi: 10.1016/j.bcp.2010.09.021. Epub 2010 Sep 29.

PMID:
20887714
9.

Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.

Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N.

Glycobiology. 2009 Dec;19(12):1511-24. doi: 10.1093/glycob/cwp130. Epub 2009 Aug 28.

PMID:
19717493
10.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

11.

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.

Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24.

PMID:
19632304
13.

A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice.

Ledoux D, Hamma-Kourbali Y, Di Benedetto M, Foucault-Bertaud A, Oudar O, Sainte-Catherine O, Lecouvey M, Kraemer M.

Anticancer Drugs. 2006 Apr;17(4):479-85.

PMID:
16550007
14.

Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro.

Muller S, Migianu E, Lecouvey M, Kraemer M, Oudar O.

Anticancer Res. 2005 Jul-Aug;25(4):2655-60.

15.

Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro.

Guenin E, Ledoux D, Oudar O, Lecouvey M, Kraemer M.

Anticancer Res. 2005 Mar-Apr;25(2A):1139-45.

16.

A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis.

Hamma-Kourbali Y, Di Benedetto M, Ledoux D, Oudar O, Leroux Y, Lecouvey M, Kraemer M.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):816-23.

PMID:
14550277
17.

Spatial organization of three-dimensional cocultures of adriamycin-sensitive and -resistant human breast cancer MCF-7 cells.

Starzec A, Briane D, Kraemer M, Kouyoumdjian JC, Moretti JL, Beaupain R, Oudar O.

Biol Cell. 2003 Jul;95(5):257-64.

PMID:
12941523
18.

Transfer into a mesothelioma cell line of tumor suppressor gene p16 by cholesterol-based cationic lipids.

Piperno-Neumann S, Oudar O, Reynier P, Briane D, Cao A, Jaurand MC, Naejus R, Kraemer M, Breau JL, Taillandier E.

Biochim Biophys Acta. 2003 Apr 1;1611(1-2):131-9.

19.

Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR Complexes.

Hamma-Kourbali Y, Vassy R, Starzec A, Le Meuth-Metzinger V, Oudar O, Bagheri-Yarmand R, Perret G, Crépin M.

J Biol Chem. 2001 Oct 26;276(43):39748-54. Epub 2001 Aug 20.

20.

Spheroids: relation between tumour and endothelial cells.

Oudar O.

Crit Rev Oncol Hematol. 2000 Nov-Dec;36(2-3):99-106. Review.

PMID:
11033300
21.

Expression and regulation of intercellular adhesion molecule-1 (ICAM-1) in organotypic cultures of rat liver tissue.

Oudar O, Moreau A, Feldmann G, Scoazec JY.

J Hepatol. 1998 Dec;29(6):901-9.

PMID:
9875636
22.

N-ethylmaleimide-inhibited electrogenic K+ secretion in the ampulla of the frog semicircular canal.

Ferrary E, Bernard C, Oudar O, Loiseau A, Sterkers O, Amiel C.

J Physiol. 1993 Feb;461:451-65.

23.

Immunolocalization of a specific type of prosome close to the bile canaliculi in fetal and adult rat liver.

Briane D, Olink-Coux M, Vassy J, Oudar O, Huesca M, Scherrer K, Foucrier J.

Eur J Cell Biol. 1992 Feb;57(1):30-9.

PMID:
1639091
24.

A cytochemical procedure for determination of Na+,K(+)-ATPase activity in MDCK cells.

Shahedi M, Laborde K, Lelongt B, Oudar O, Sachs C.

Kidney Int. 1992 Feb;41(2):455-61. No abstract available.

25.

Secretion of endolymph by the isolated frog semicircular canal.

Ferrary E, Bernard C, Oudar O, Sterkers O, Amiel C.

Acta Otolaryngol. 1992;112(2):294-8.

PMID:
1604995
26.

Differences in rat kidney morphology between males, females and testosterone-treated females.

Oudar O, Elger M, Bankir L, Ganten D, Ganten U, Kriz W.

Ren Physiol Biochem. 1991 May-Jun;14(3):92-102.

PMID:
1707550
27.

Antidiuretic-hormone-induced morphological changes in the ampullary epithelium of the frog semicircular canal.

Oudar O, Ferrary E, Feldmann G.

Eur Arch Otorhinolaryngol. 1991;248(7):386-9.

PMID:
1747244
28.

Adenylate cyclase in the semicircular canal. Hormonal stimulation and ultrastructural localization.

Ferrary E, Oudar O, Bernard C, Friedlander G, Feldmann G, Sterkers O.

Acta Otolaryngol. 1991;111(2):281-5.

PMID:
1648855
30.

Sodium transfer from endolymph through a luminal amiloride-sensitive channel.

Ferrary E, Bernard C, Oudar O, Sterkers O, Amiel C.

Am J Physiol. 1989 Aug;257(2 Pt 2):F182-9.

PMID:
2548398
31.

Ultrastructural study of the semicircular canal cells of the frog Rana esculenta.

Oudar O, Ferrary E, Feldmann G.

Anat Rec. 1988 Mar;220(3):328-34.

PMID:
3259115

Supplemental Content

Support Center